Clinical Trials Browser

Colorectal Neoplasms

NCT06999785 2026-04-06

OXYBAR

Phase NA Recruiting

60 enrolled

Tumor-Agnostic

Neoplasms

NCT03654105 2026-03-27

SMILE

Phase 2 Active not recruiting

2,000 enrolled

Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05766046 2026-03-27

RISP

Phase NA Active not recruiting

7,324 enrolled

Thoracic

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT02780128 2026-03-10

NEPENTHE

Phase 1 Terminated

66 enrolled

CNS

Neoplasms, Neuroblastoma

NCT03568188 2026-02-24

FOCALE

Phase 2 Completed

174 enrolled

Genitourinary

Prostatic Neoplasms

NCT06346054 2026-02-17

MAGEC

Phase NA Recruiting

1,000 enrolled

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT05848050 2025-11-24

METALIQ

Phase NA Completed

21 enrolled

CNS

Brain Neoplasms

NCT04424719 2025-09-03

SALOME

Phase NA Recruiting

700 enrolled

Dermatologic

Uveal Melanoma

NCT06989814 2025-08-11

SMART

Phase NA Recruiting

50 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

NCT06620835 2025-07-29

OPTALK

Phase 2 Recruiting

45 enrolled

Thoracic

Lung Neoplasms

NCT06929481 2025-05-02

Screening With a DNA Blood Test to Address Colorectal Cancer Inequities

Phase NA Enrolling by invitation

340 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

China Colorectal Cancer Screening Trial 1 (C-Cost1)

OXYBAR

SMILE

RISP

NEPENTHE

FOCALE

MAGEC

METALIQ

SALOME

SMART

OPTALK

Screening With a DNA Blood Test to Address Colorectal Cancer Inequities